ASSET PURCHASE AGREEMENT between RELIANT PHARMACEUTICALS, INC. and BRAINTREE LABORATORIES, INC. Dated as of June 24, 2005Asset Purchase Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT, dated as of June 24, 2005 (this “Agreement”), is entered into by and between Reliant Pharmaceuticals, Inc., a Delaware corporation (“Reliant”), and Braintree Laboratories, Inc., a Massachusetts corporation (“Purchaser”). Each of Reliant and Purchaser is sometimes referred to herein, individually, as a “Party” and, collectively, as the “Parties.” All capitalized terms used herein shall have the meanings specified in Article I below or elsewhere in this Agreement, as applicable.
AMENDED AND RESTATED PROMOTION AGREEMENT BETWEEN NOVARTIS PHARMACEUTICALS CORPORATION AND RELIANT PHARMACEUTICALS, INC.Promotion Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
AMENDED AND RESTATED MANUFACTURING AND PACKAGING AGREEMENTManufacturing and Packaging Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Quality Agreement does not supercede or amend any provisions in the Supply Agreement between Reliant Pharmaceutical (Reliant) and Cardinal Health (Cardinal) dated April 14, 2005 (as may be amended from time to time, the “Agreement”). In the event of a conflict between the terms of the Agreement and this Quality Agreement, the Agreement shall be controlling.
AMENDMENT NO. 1 TO LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This AMENDMENT NO. 1 TO LICENSE AND SUPPLY AGREEMENT (this “Amendment”) is entered into as of November 19, 2004, by and between PRONOVA BIOCARE A.S., a corporation incorporated under the laws of Norway (“Pronova”), located at Postboks 420, Vollsveien 6, NO-1327, Lysaker, Norway, and Reliant Pharmaceuticals, Inc., a Delaware corporation (“Reliant”), located at 110 Allen Road, Liberty Corner, New Jersey, 07938.
MANUFACTURING AGREEMENT between ABBOTT GMBH & CO. KG and RELIANT PHARMACEUTICALS, LLC Dated as of December 3, 2003Manufacturing Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • Illinois
Abbott has agreed to manufacture the Products in accordance with all cGMP’s, Product Specifications and all applicable federal, state, and local laws and regulations.
ASSET PURCHASE AGREEMENT by andAsset Purchase Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT Dated as of January 27, 2000 between EURAND AMERICA, NC. Vandalia, Ohio 45377 and RELIANT PHARMACEUTICALS New York, NY 10019 for EXTENDED RELEASE PROPRANOLOLDevelopment, License and Supply Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT, dated as of January 27, 2000, between EURAND AMERICA, INC., a corporation organized under the laws of Nevada, with its principal offices at 845 Center Drive, Vandalia, Ohio 45377 (“EURAND”), and RELIANT PHARMACEUTICALS, INC., a corporation organized under the laws of the State of Delaware, with its principal offices at 125 West 55th Street, 11th floor, New York, New York (“RELIANT”);
McKesson Corporation Core Distribution AgreementMcKesson Corporation Core Distribution Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This agreement (“Agreement”) is entered into between McKesson Corporation (“McKesson”), a pharmaceutical distributor, and Reliant Pharmaceuticals, Inc. (“Manufacturer”), a pharmaceutical manufacturer.
SUPPLY AGREEMENTSupply Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Shasun has agreed to manufacture Nizatidine API in accordance with all cGMP’s, Product Specifications and all applicable federal, state, and local laws and regulations.
MASTER SERVICES AGREEMENTMaster Services Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations
This Master Agreement (“Agreement”) made this 11th day of December, 2001, by and between Reliant Pharmaceutical, LLC, with its principal executive offices located at Liberty Corner, New Jersey (“Sponsor”), and PPD Development, LLC, a Texas limited liability company with its principal executive offices located at 3151 17th Street Extension, Wilmington, North Carolina 28412, USA (“PPD”).
AMENDMENT NO. 2 TO MANUFACTURING AGREEMENT BETWEEN ABBOTT LABORATORIES AND RELIANT PHARMACEUTICALS, INC.Manufacturing Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • Illinois
THIS SECOND AMENDMENT TO MANUFACTURING AGREEMENT (this “Second Amendment”) is made as of this day of December 2005 by and between Reliant Pharmaceuticals, Inc., a Delaware corporation (“Buyer”) and Abbott Laboratories (“Seller”).
RELIANT PHARMACEUTICALS, INC -ATP, LLC SERVICES AGREEMENTAn Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This AGREEMENT, effective this 12th day of February, 2001 by and between RELIANT Pharmaceuticals, Inc., a Delaware limited liability company formed in Delaware, having a place of business at 721 Route 202/206 South, Bridgewater, New Jersey 08807 (hereinafter referred to as “RELIANT”), and ATP, LLC, d/b/a PPD ATP, a North Carolina limited liability company (hereinafter referred to as “ATP”).
CONFIDENTIAL LICENSE & SUPPLY AGREEMENT dated as of August 9, 2004 between PRONOVA BIOCARE A.S. Postboks 420, Vollsveien 6, NO-1327 Lysaker, Norway (hereinafter “PRONOVA”) and RELIANT PHARMACEUTICALS, INC. (hereinafter “RELIANT”) collectively referred...Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WHEREAS, PRONOVA owns and/or controls certain intellectual property rights and know-how with respect to a pharmaceutical product known as Omacor® and has the manufacturing skills to produce Omacor®;
RELIANT PHARMACEUTICALS-PPD MEDICAL COMMUNICATIONS PRODUCT SAFETY/PHARMACOVIGILANCE SERVICES (PSPV) AGREEMENTAgreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This AGREEMENT, executed this 25th day of February, 2003, by and between Reliant Pharmaceuticals, LLC, a New Jersey limited liability company, having a place of business at 110 Allen Road, Liberty Corner. NJ 07938, (hereinafter referred to as “CLIENT”), and ATP, LLC, dba PPD Medical Communications, a North Carolina limited liability company (hereinafter referred to as “PPD”).
RELIANT-ATP MEDICAL LETTER WRITING SERVICES AGREEMENTServices Agreement • October 26th, 2007 • Reliant Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This AGREEMENT, executed this 18th day of December, 2000, is made by and between Reliant Pharmaceuticals, LLC, a Delaware limited liability company having a place of business at 721 Route 202/206 South, Bridgewater, New Jersey 08807 (hereafter referred to as “Reliant”), and ATP, LLC, dba PPD ATP, LLC, a North Carolina limited liability company (hereinafter referred to as “ATP”).
February 23, 2006 Novartis Consumer Heath, Inc. Parsippany, NJ 07054 Attn: Mr. Ivan Marti Dear Ivan:Reliant Pharmaceuticals, Inc. • October 26th, 2007 • Pharmaceutical preparations
This letter will confirm the agreement between Novartis Consumer Health, Inc. (“Manufacturer”) and Reliant Pharmaceuticals, Inc. (“Company’s concerning certain outstanding amounts for which payment is due from Company to Manufacturer and such other matters as set forth herein. Capitalized teams used but not otherwise defined have the meanings ascribed to them in the Packaging and Supply Agreement between the parties dated March, 2004 (the “Agreement”).
